about
ZNF703 gene amplification at 8p12 specifies luminal B breast cancerFOXP3 transcription factor: a candidate marker for susceptibility and prognosis in triple negative breast cancerEnumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering.Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma.Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.Transcriptomic landscape of breast cancers through mRNA sequencing.Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.Securin promotes the identification of favourable outcome in invasive breast cancer.Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.FISH as an effective diagnostic tool for the management of challenging melanocytic lesions.Single-cell profiling approaches to probing tumor heterogeneity.A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients.Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer
P2860
Q24293333-0B96A3A1-C883-453A-A3DC-1CC4AEFDA193Q33616070-702EF94E-0EC5-4A82-8950-9DDEF48EDF05Q33669571-8F168F5E-1ECA-4BD4-9374-01B0163DA332Q33776184-924663FF-67C2-4C13-AD05-F5573B7B1312Q33826097-CFD38B5A-F0B5-4568-8145-85B67E332822Q34048090-976A32B3-FDD3-4AFE-B92E-E075909EF1BBQ34923557-545E78CA-83A0-4C44-954F-E94CFE511593Q35083016-493791E8-DAE4-4FCB-8177-EC9311E3AF35Q35589437-DD4162FD-E1AE-43D5-B5C0-36E780B8EF58Q35755270-5E26D622-50C5-45A1-9ACD-F97437D4E9E6Q36228444-6A9D768C-87E0-42C1-BE35-46956D3E71EBQ36503490-88240650-7C26-42F6-A6EF-3CB4CA55B2DEQ37345354-4D7F8785-A99A-40C9-9E52-4A27897C8081Q37383276-3F77F59E-4F99-4765-AFE5-98FD741FDF02Q37716326-964BDFDD-43B3-47BD-A536-6DC4A645F7EFQ37809456-B7BE1585-C200-49CD-968D-AE4BE35463EFQ37915648-7A2A8CC2-379E-4ACF-BBC9-6EF8E23D97AFQ38704068-56EDD565-A9B1-4BDD-A99D-67F0A52BB848Q42438922-5F395507-0CEB-46A3-9CE5-5F3E0F4973AAQ42498742-3A6D9A0A-5414-4961-85B7-2E8E5BB52BFCQ58568604-3AB3D30F-54BC-438B-8624-B89D2A345402
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The role of molecular analysis in breast cancer.
@ast
The role of molecular analysis in breast cancer.
@en
The role of molecular analysis in breast cancer.
@nl
type
label
The role of molecular analysis in breast cancer.
@ast
The role of molecular analysis in breast cancer.
@en
The role of molecular analysis in breast cancer.
@nl
prefLabel
The role of molecular analysis in breast cancer.
@ast
The role of molecular analysis in breast cancer.
@en
The role of molecular analysis in breast cancer.
@nl
P1433
P1476
The role of molecular analysis in breast cancer.
@en
P2093
Caterina Marchio
Felipe C Geyer
P356
10.1080/00313020802563536
P577
2009-01-01T00:00:00Z